Article
SLCO1B1 Polymorphisms are Associated With Drug Intolerance in Childhood Leukemia Maintenance Therapy.
Journal of pediatric hematology/oncology - 1 Jul 2018
Eldem İrem, Yavuz Duygu, Cumaoğullari Özge, İleri Talia, Ünal İnce Elif, Ertem Mehmet, Doğanay Erdoğan Beyza, Bindak Recep, Özdağ Hilal, Şatiroğlu-Tufan N Lale, Uysal L Zümrüt
Abstract excerpt
BACKGROUND: Therapy discontinuations and toxicities occur because of significant interindividual variations in 6-mercaptopurine (6-MP) and methotrexate (MTX) response during maintenance therapy of childhood acute lymphoblastic leukemia (ALL). 6-MP/MTX intolerance in some of the patients cannot be explained by thiopurine S-methyl transferase (TPMT) gene variants. In this study, we aimed to investigate candidate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
